GPR183 Antagonism Reduces Macrophage Infiltration in Influenza and SARS-CoV-2 Infection

Researchers identified the mechanisms that drive immune cell recruitment in the lung during viral respiratory infections and identify novel drug targets to reduce inflammation and disease severity.